Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.

2.50
Hdl Handle:
http://hdl.handle.net/10033/621354
Title:
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
Authors:
Ciccocioppo, Rachele; Dos Santos, Claudia C; Baumgart, Daniel C; Cangemi, Giuseppina C; Cardinale, Vincenzo; Ciacci, Carolina; De Coppi, Paolo; Haldar, Debashis; Klersy, Catherine; Nostro, M Cristina; Ott, Michael; Piemonti, Lorenzo; Tomei, Alice A; Uygun, Basak; Vetrano, Stefania; Orlando, Giuseppe
Abstract:
A summary of the First Signature Series Event, "Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases," held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.
Citation:
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. 2018, 20 (3):461-476 Cytotherapy
Journal:
Cytotherapy
Issue Date:
Mar-2018
URI:
http://hdl.handle.net/10033/621354
DOI:
10.1016/j.jcyt.2017.12.004
PubMed ID:
29398624
Language:
en
ISSN:
1477-2566
Appears in Collections:
publications of the TwinCore unit Infection immunology

Full metadata record

DC FieldValue Language
dc.contributor.authorCiccocioppo, Racheleen
dc.contributor.authorDos Santos, Claudia Cen
dc.contributor.authorBaumgart, Daniel Cen
dc.contributor.authorCangemi, Giuseppina Cen
dc.contributor.authorCardinale, Vincenzoen
dc.contributor.authorCiacci, Carolinaen
dc.contributor.authorDe Coppi, Paoloen
dc.contributor.authorHaldar, Debashisen
dc.contributor.authorKlersy, Catherineen
dc.contributor.authorNostro, M Cristinaen
dc.contributor.authorOtt, Michaelen
dc.contributor.authorPiemonti, Lorenzoen
dc.contributor.authorTomei, Alice Aen
dc.contributor.authorUygun, Basaken
dc.contributor.authorVetrano, Stefaniaen
dc.contributor.authorOrlando, Giuseppeen
dc.date.accessioned2018-04-13T11:14:48Z-
dc.date.available2018-04-13T11:14:48Z-
dc.date.issued2018-03-
dc.identifier.citationProceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. 2018, 20 (3):461-476 Cytotherapyen
dc.identifier.issn1477-2566-
dc.identifier.pmid29398624-
dc.identifier.doi10.1016/j.jcyt.2017.12.004-
dc.identifier.urihttp://hdl.handle.net/10033/621354-
dc.description.abstractA summary of the First Signature Series Event, "Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases," held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleProceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.en
dc.identifier.journalCytotherapyen
This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.